HOME >> BIOLOGY >> NEWS
NIH selects Pittsburgh institute as leader for HIV/AIDS prevention efforts

Pittsburgh, June 30 The University of Pittsburgh-affiliated Magee-Womens Research Institute is one of six institutions selected to lead HIV/AIDS prevention and treatment efforts by the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH). Estimated at $285 million in funding for the first year, these leadership group awards represent the first step of a two-part restructuring process of the NIAID's clinical trials networks.

Sharon L. Hillier, Ph.D., professor of obstetrics, gynecology and reproductive sciences and of molecular genetics and biochemistry at the University of Pittsburgh School of Medicine, is principal investigator for the Pittsburgh consortium, which has been designated to lead the Microbicide Trials Network (MTN). The mission of the MTN is to develop new drugs and drug delivery systems to prevent HIV and its spread.

"The leading method of transmission for HIV/AIDS infection today is heterosexual intercourse," said Dr. Hillier, who also is a senior investigator at the Magee-Womens Research Institute. "And in many parts of the world, a woman's single biggest risk factor for the acquisition of HIV is being married. Currently, women have no way to protect themselves except condoms, and women do not control condom use."

Dr. Hillier's group is involved in evaluating drugs for the prevention of sexually transmitted infections such as HIV. Clinical trials have been designed to support the licensing of new agents for the prevention of HIV that could be used by women at risk of infection both in the U.S. and internationally. NIAID's decision to fund the MTN reflects a growing recognition that novel approaches to prevention will be needed to slow the epidemic of AIDS.

"Pittsburgh proved its scientific worth more than 50 years ago when the development of the Salk vaccine signaled an end to the scourge of polio," said Arthur S. Levine, M.D., senior vice
'"/>

Contact: Michele Baum
BaumMD@upmc.edu
412-647-3555
University of Pittsburgh Medical Center
30-Jun-2006


Page: 1 2 3

Related biology news :

1. Energy department selects 3 Bioenergy Research Centers for $375 million in federal funding
2. EPA selects Phylonix to screen compound library in zebrafish
3. OneWorld Health selects Odyssey Research for phase 4 study in India
4. NIH selects Childrens Hospital as Center of Excellence to train future generations of scientists
5. NIH selects Purdue to use phi29 DNA packaging motor for National Nanomedicine Development Center
6. IUBMB selects Wiley to publish Biochemistry and Molecular Biology Education
7. EMBO selects Europes best young independent scientists
8. NIH selects Burnham Institute for Exploratory Center for Human Embryonic Stem Cell Research
9. NHGRI selects 13 new targets for large-scale sequencing program
10. NIH gives $8M to University of Pittsburgh School of Medicine for myositis research
11. University of Pittsburgh School of Medicine researchers develop off-the-shelf vascular grafts

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2017)... , May 16, 2017   Bridge Patient ... organizations, and MD EMR Systems , an ... partner for GE, have established a partnership to ... product and the GE Centricity™ products, including Centricity ... These new integrations will allow ...
(Date:4/18/2017)... 2017  Socionext Inc., a global expert in SoC-based imaging and ... the M820, which features the company,s hybrid codec technology. A demonstration ... Probe, Inc., will be showcased during the upcoming Medtec Japan at ... the Las Vegas Convention Center April 24-27. ... Click here for an ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ., a ... Webinar titled, “Pathology is going digital. Is your lab ready?” with Dr. Nicolas ... practices and how Proscia improves lab economics and realizes an increase in diagnostic ...
(Date:10/11/2017)... Florida (PRWEB) , ... October 11, 2017 , ... ... Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 ... for the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane ...
(Date:10/10/2017)... Oct. 10, 2017 International research firm Parks Associates ... speak at the TMA 2017 Annual Meeting , October 11 in ... the residential home security market and how smart safety and security products ... Parks Associates: Smart ... "The residential security market ...
(Date:10/9/2017)... ... ... The award-winning American Farmer television series will feature 3 Bar Biologics in ... 8:30aET on RFD-TV. , With global population estimates nearing ten billion people by ... feed a growing nation. At the same time, many of our valuable resources are ...
Breaking Biology Technology:
Cached News: